This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Adtalem (ATGE) Up on Financial Services Unit Sale Announcement
by Zacks Equity Research
Adtalem Global Education (ATGE) to meet the rapidly growing and unmet demand for healthcare professionals in the United States.
American Public (APEI) Buys Rasmussen, Boosts Nursing Footprint
by Zacks Equity Research
American Public Education (APEI) is now a major educator of pre-licensure nursing students in the United States following the acquisition of Rasmussen.
Adtalem (ATGE) Revamps AFC Compliance Professional Program
by Zacks Equity Research
Adtalem Global Education (ATGE) to help students learn audit best practices with advanced AFC certification program.
Adtalem (ATGE) Partners Stride, Motivates Students for Nursing
by Zacks Equity Research
Adtalem Global Education (ATGE) and Stride are set to create pathways for addressing nursing shortages.
Adtalem (ATGE) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Adtalem Global Education's (ATGE) Q4 earnings are likely to have benefited from strong demand. Yet, increased marketing spend may have put pressure on the bottom line.
American Public (APEI) Set to Acquire GSUSA, Fortify APUS
by Zacks Equity Research
American Public Education (APEI) is set to acquire GSUSA for $1 million.
American Public (APEI) Q2 Earnings Lag, Fall Y/Y, Stock Down
by Zacks Equity Research
American Public Education's (APEI) second-quarter results are hurt by a challenging enrollment environment at APUS.
Stride (LRN) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Stride's (LRN) fourth-quarter fiscal 2021 earnings are likely to have benefited from strong demand for online learning options and cost-effective moves.
Universal Technical Institute (UTI) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Universal Technical (UTI) delivered earnings and revenue surprises of 100.00% and 1.29%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Universal Technical Institute (UTI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Universal Technical (UTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 School Stocks Surviving Industry Challenges
by Shrabana Mukherjee
Although virtual delivery of education and prudent cost-saving initiatives are likely to open up opportunities for BFAM, ATGE, LRN, PRDO and LINC, economic slowdown and regulations may create hurdles for the Zacks Schools industry.
Adtalem (ATGE) Unveils Diversity and Inclusion Certificate
by Zacks Equity Research
The CPE program by Adtalem Global Education's (ATGE) Becker is designed to introduce the benefits of integrating DEBI into the workplace.
RISE (REDU) Launches WhySTEAM and Hiyeah, Boosts Offerings
by Zacks Equity Research
RISE's (REDU) launch of two new aptitude training products is set to accelerate the development of the aptitude training ecosystem.
Adtalem (ATGE), LCMC Health Launch Tuition-Free Nursing Program
by Zacks Equity Research
Adtalem Global Education's (ATGE) Chamberlain University to serve the growing demand for nurses.
American Public (APEI) Stock Down Despite Q1 Earnings Beat
by Zacks Equity Research
American Public Education's (APEI) first-quarter results benefit from solid enrollment growth.
Universal Technical Institute (UTI) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Universal Technical (UTI) delivered earnings and revenue surprises of -133.33% and -0.18%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Universal Technical Institute (UTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Universal Technical (UTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 School Stocks to Navigate Industry Challenges
by Shrabana Mukherjee
Economic slowdown may create hurdles for the Zacks Schools industry. Meanwhile, virtual delivery of education and prudent cost-saving initiatives are likely to open up opportunities for GPX, ATGE, APEI, LRN, and LINC.
Universal Technical Institute (UTI) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Universal Technical (UTI) delivered earnings and revenue surprises of -116.67% and -8.01%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Universal Technical Institute (UTI) Q1 Earnings Expected to Decline
by Zacks Equity Research
Universal Technical (UTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Universal Technical Institute (UTI) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Universal Technical (UTI) delivered earnings and revenue surprises of -25.00% and -14.48%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Universal Technical Institute (UTI) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Universal Technical (UTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 School Stocks Trying to Survive Industry Challenges
by Shrabana Mukherjee
Economic slowdown may create hurdles for the Zacks Schools industry. Meanwhile, virtual delivery of education along with prudent cost-saving initiatives will open up opportunities for LRN, PEI and LOPE.
LRN vs. UTI: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
LRN vs. UTI: Which Stock Is the Better Value Option?
GPX or UTI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GPX vs. UTI: Which Stock Is the Better Value Option?